These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients. Habtewold A, Amogne W, Makonnen E, Yimer G, Riedel KD, Ueda N, Worku A, Haefeli WE, Lindquist L, Aderaye G, Burhenne J, Aklillu E. J Antimicrob Chemother; 2011 Oct; 66(10):2350-61. PubMed ID: 21846671 [Abstract] [Full Text] [Related]
25. Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study. Olagunju A, Bolaji O, Amara A, Waitt C, Else L, Adejuyigbe E, Siccardi M, Back D, Khoo S, Owen A. Clin Infect Dis; 2015 Aug 01; 61(3):453-63. PubMed ID: 25882300 [Abstract] [Full Text] [Related]
27. Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort. Carr DF, la Porte CJ, Pirmohamed M, Owen A, Cortes CP. J Antimicrob Chemother; 2010 Sep 01; 65(9):1889-93. PubMed ID: 20639527 [Abstract] [Full Text] [Related]
28. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ. AIDS Res Hum Retroviruses; 2018 Nov 01; 34(11):982-992. PubMed ID: 29973058 [Abstract] [Full Text] [Related]
33. Efavirenz plasma concentrations and cytochrome 2B6 polymorphisms. Lindfelt T, O'Brien J, Song JC, Patel R, Winslow DL. Ann Pharmacother; 2010 Oct 01; 44(10):1572-8. PubMed ID: 20841522 [Abstract] [Full Text] [Related]
34. Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients. Elens L, Vandercam B, Yombi JC, Lison D, Wallemacq P, Haufroid V. Pharmacogenomics; 2010 Sep 01; 11(9):1223-34. PubMed ID: 20860463 [Abstract] [Full Text] [Related]
35. Impact of Single Nucleotide Polymorphisms on Plasma Concentrations of Efavirenz and Lopinavir/Ritonavir in Chinese Children Infected with the Human Immunodeficiency Virus. Liu X, Ma Q, Zhao Y, Mu W, Sun X, Cheng Y, Zhang H, Ma Y, Zhang F. Pharmacotherapy; 2017 Sep 01; 37(9):1073-1080. PubMed ID: 28718515 [Abstract] [Full Text] [Related]
39. CYP2B6 Genotype-Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers. Metzger IF, Dave N, Kreutz Y, Lu JBL, Galinsky RE, Desta Z. Clin Transl Sci; 2019 Nov 01; 12(6):657-666. PubMed ID: 31339646 [Abstract] [Full Text] [Related]